Finland Investigates Cancer Drug Reimbursement Controversy

Yle investigated the background of a 'cancer drug controversy' in Finland, revealing that the issue primarily stems from an increase in the cost of one specific cancer medication, with more new drugs expected to be unreimbursed by Kela.